Schedule 13G ownership disclosure

APREA THERAPEUTICS INC

Security class unavailable · CUSIP: 03836J102

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
184,964
Percent of class
0.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-21-000500
Form type
SC 13G
Filer
Aprea Therapeutics, Inc.
CIK
CIK 1781983
Filed
Oct 12, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub